Latest Vena Res Inc (VNARF) Headlines Vena Issues Shares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Vena Res Inc (VNARF) Headlines

Vena Issues Shares to Settle Debt and Provides Board Update
CNW Group - Wed Aug 21, 4:00PM CDT
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) announces that it has entered into debt settlement agreements to settle trade payables for the aggregate settlement amount of $150,350.62, through the issuance of an aggregate of 1,642,651 common shares in the capital of the Company, at an average price of $0.092 per common share. Included in these debt settlements are 189,994 common shares issuable to insiders of the Company. Common shares issued will be subject to a four-month and a day hold period from the date of issuance in accordance with applicable securities laws. The transactions contemplated under the debt settlement agreements are subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including that of the Toronto Stock Exchange.

Vena Announces Annual and Special Meeting Voting Results
CNW Group - Tue Jun 25, 4:00PM CDT
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) is pleased to announce the voting results for the annual and special meeting of shareholders held earlier today (the "Meeting").

Vena Cancels Non-binding Option on Esquilache, Pucara and Amantina Projects and Starts Discussions with Other Interested Groups
CNW Group - Mon Jun 03, 6:00AM CDT
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) announces that after weeks of negotiating a final binding agreement with a private Peruvian mining company, the potential option on the Esquilache, Pucara and Amantina projects located in the department of Puno, Peru (collectively, the "Projects") has been terminated and the Company has begun discussions with four other interested groups. The Company had announced the non-binding Letter of Intent on March 8(th) which would have would have resulted in a joint venture on the Projects.

Vena Issues Shares to Settle Debt
CNW Group - Thu Apr 25, 8:46PM CDT
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) announces that it has entered into debt settlement agreements to settle trade payables for the aggregate settlement amount of $158,255, through the issuance of an aggregate of 791,273 common shares in the capital of the Company, at a price of $0.20 per common share. The common shares issued will be subject to a four-month and a day hold period from the date of issuance in accordance with applicable securities laws. The transactions contemplated under the debt settlement agreements are subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including that of the Toronto Stock Exchange.

Vena Enters into Letter of Intent to Option the Esquilache, Pucara and Amantina Projects for a Minimum US$30 Million Investment in Exploration, Mine Development and Mill Construction
CNW Group - Fri Mar 08, 1:00AM CST
Vena Resources Inc. ("Vena" or the "Company") (TSX: VEM), (LIMA: VEM), (Frankfurt: V1RA), (OTC-BB: VNARF), (Xetra®: V1RA.DE) announces that the Company has entered into a non-binding Letter of Intent ("LOI") with a private Peruvian mining company (the "Optionee") to earn up to a 75% interest in the Amantina, Esquilache and Pucara projects (collectively, the "Projects") located in the department of Puno, Peru.

Vena Regains Control of the 18,900 Hectare Amantina Property Adjacent to the Esquilache Silver Project in Peru
CNW Group - Fri Mar 01, 1:00AM CST
Vena Resources Inc. ("Vena" or the "Company") (TSX: VEM, LIMA: VEM, Frankfurt: V1RA, OTC-BB: VNARF, Xetra®: V1RA.DE) announces that the Company has regained control of its 100% owned 18,900 hectare Amantina property in Peru, contiguous to the Company's strategic Esquilache silver project. Since January 2010, the Amantina property has been operated by a wholly-owned subsidiary of Gold Fields Limited ("Gold Fields") under a Joint Venture agreement, however Gold Fields has agreed to waive its right to vest a 51% interest in the Joint Venture in exchange for a 2% Net Smelter Return.

Vena Announces Positive Results of Surface Sampling at the Esquilache Silver Project
CNW Group - Tue Jan 15, 1:00AM CST
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) announces the results of the initial surface sampling phase of the current exploration program being conducted on the Esquilache silver project located in southeastern Peru. The sampling confirmed the continuity of high grade silver values in the surface outcrops of the Sepulveda, Creston, Elvira, Katty and Julian veins with values up to 25 opt Ag (ounces per tonne silver), 5.68% Pb (lead) and 1.45% Zn (zinc) and complements the positive preliminary metallurgical test results that were reported in a press release on January 7, 2013.

Vena Announces Positive Metallurgical Test Results from the Esquilache Silver Project
CNW Group - Mon Jan 07, 1:00AM CST
Vena Resources Inc. (the "Company" or "Vena") (TSX: VEM, Peru: VEM, Germany: V1RA, USA: VNARF) announces positive results on the preliminary metallurgical testing of outcropping veins and mine dumps as part of the recently initiated program to evaluate near surface resources on its 100% owned Esquilache project located in southern Peru. The metallurgical tests have been conducted on composite representative samples from the Sepulveda and Elvira veins as well as the principal dumps confirming that the Esquilache project can produce commercially viable concentrates of silver-lead (Ag-Pb) and zinc (Zn) and that the mineralization is processable by standard metallurgical methods.

Vena Res Inc (VNARF) Stock Research Links

VNARF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on CDW's Market Position and P/E Ratio Analysis

Updated Category News Views 123

Analyzing CDW's Current Market Performance CDW Inc.'s current stock price stands at $164.29, reflecting a notable increase of 2.59% during the ongoing market session. Despite this uptick, shareholders might be concerned as the stock has experienced a decline of 6.53% over the past month and a more significant drop of 24.18% over the last year. With these figures, it...

Continue Reading
What the Recent Earnings Report Means for FactSet Research

Updated Category News Views 135

FactSet Research Exceeds Expectations in Q1 Performance FactSet Research Systems Inc. (NYSE: FDS) has reported first-quarter results that exceeded analyst expectations, showcasing strong performance in a competitive financial market. The company achieved first-quarter sales totaling $607.6 million, surpassing the anticipated $600.5 million, which reflects a commendable...

Continue Reading
Dime Community Bancshares Unveils Executive Transition Plans

Updated Category News Views 180

Dime Community Bancshares Executive Changes Dime Community Bancshares, Inc. (NASDAQ: DCOM) recently announced significant changes in its leadership team as part of a strategic succession plan. This initiative reflects the company’s commitment to fostering a robust executive structure and enhancing its operational growth. Leadership Transition Details As Dime prepares...

Continue Reading
Hygiene Products Industry on Track to Reach $14.62 Billion

Updated Category News Views 112

Overview of the Antiseptic Products Market The global antiseptic products market is projected to experience remarkable growth, reaching an estimated value of USD 10.85 billion in 2025, and anticipated to climb to USD 14.62 billion by 2032. This represents a compound annual growth rate (CAGR) of 4.35% during the period. As health-conscious consumers become increasingly...

Continue Reading
China's Enduring Commitment to Global Peace and Prosperity

Updated Category News Views 91

China's Historical Role in the UN The United Nations (UN) stands as a testament to humanity's resolve for peace, shaped significantly by historical events like the World Anti-Fascist War. This war saw the Allies, including China, rally against the Axis powers, fostering a crucial international alliance. Founded as a result of collective victories, the UN embodies the...

Continue Reading